Concomitant tamoxifen or letrozole for optimal oocyte yield during fertility preservation for breast cancer: the TAmoxifen or Letrozole in Estrogen Sensitive tumors (TALES) randomized clinical trial
Joseph M. Letourneau, Flor Juarez‐Hernandez, Kaitlyn Wald, Salustiano Ribeiro, Ange Wang, Charles E. McCulloch, Evelyn Mok-Lin, Marek Doležal, A. Jo Chien, Marcelle I. Cedars, Mitchell P. Rosen
Topics & Concepts
LetrozoleTamoxifenFertility preservationBreast cancerAntiestrogenMedicineGynecologyOncologyEstrogenConcomitantRandomized controlled trialFertilitySelective estrogen receptor modulatorOvarian reserveReproductive medicineInternal medicineCancerInfertilityBiologyPregnancyEnvironmental healthGeneticsPopulationReproductive Biology and FertilityBreast Cancer Treatment StudiesCancer Risks and Factors